State Street Corp Vaxart, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, State Street Corp holds 688,845 shares of VXRT stock, worth $323,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
688,845
Previous 594,145
15.94%
Holding current value
$323,757
Previous $505,000
10.1%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VXRT
# of Institutions
102Shares Held
35.8MCall Options Held
83.1KPut Options Held
120K-
Sio Capital Management, LLC New York, NY11.5MShares$5.41 Million2.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$4.74 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.99MShares$1.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.6MShares$1.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$833,9420.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $59.5M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...